Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
accrete, Anrui, anxiety, arm, Arthrosi, Aucentra, baseline, Biomend, book, CAMT, chemical, CONCERTO, Conversely, dollar, effector, excise, freestanding, Gilead, hard, Incyclix, inflammatory, instrument, IRA, irrevocable, issuer, itching, kinome, leadership, macroeconomic, mandatorily, metabolism, noncash, objective, orderly, peripherally, perpetual, placebo, rational, regularly, retaliatory, revert, sacituzumab, shrinkage, Sidney, skin, sleep, space, spectrum, sublease, Symposium, unilateral, urticaria, York
Removed:
addressing, backbone, conference, resistant, sparing
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view